Investors, do you find $LLY or $NVObetter ?
Both companies have very similar businesses and compete with each other. With $NVO, they may be at risk of tariffs that Trump might impose, and their drug may not be as popular in the US. Still, $NVO currently looks more interesting to me , which is why I've been shopping around this year. I think the stock is undervalued and the company has a lot of potential due to its business.
Maybe $LLY is better, but currently $NVO is more interesting. The stock has fallen a lot recently and I think this is a perfect buying opportunity.